InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ADC Therapeutics SA

ADCT Clue Score41
Switzerland Fiscal year ends December CIK 0001771910
$1.73 +8.81% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.73 −92.92% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 15 May 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Revenue1.1Operating income−125.9Net income−123.1Fiscal year 2019Revenue2.3 +105.3%Operating income−119.4Net income−116.5Fiscal year 2020Revenue0.0 −100.0%Operating income−219.3Net income−246.3Fiscal year 2021Revenue33.9Operating income−261.7Net income−230.0Fiscal year 2022Revenue74.9 +120.9%Operating income−123.3Net income−157.1EPS, diluted−2.01Fiscal year 2023Revenue69.1 −7.8%Operating income−166.0Net income−240.1EPS, diluted−2.94Fiscal year 2024Revenue70.8 +2.6%Operating income−130.7Net income−157.8EPS, diluted−1.62Fiscal year 2025Revenue81.4 +14.9%Operating income−121.5Net income−142.6EPS, diluted−1.12
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.1 2.3 0.0 33.9 74.9 69.1 70.8 81.4
Growth +105.3% −100.0% +120.9% −7.8% +2.6% +14.9%
Operating income −125.9 −119.4 −219.3 −261.7 −123.3 −166.0 −130.7 −121.5
Net income −123.1 −116.5 −246.3 −230.0 −157.1 −240.1 −157.8 −142.6
Growth
EPS, diluted n/a n/a n/a n/a −2.01 −2.94 −1.62 −1.12
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Operating margin−11,047.5%Net margin−10,797.9%Free cash flow margin−10,728.6%Fiscal year 2019Operating margin−5,102.5%Net margin−4,977.9%Free cash flow margin−5,211.1%Fiscal year 2020Fiscal year 2021Operating margin−771.6%Net margin−678.2%Free cash flow margin−698.2%Fiscal year 2022Operating margin−164.7%Net margin−209.8%Free cash flow margin−185.6%Fiscal year 2023Operating margin−240.4%Net margin−347.6%Free cash flow margin−176.5%Fiscal year 2024Operating margin−184.4%Net margin−222.8%Free cash flow margin−176.0%Fiscal year 2025Operating margin−149.3%Net margin−175.3%Free cash flow margin−173.8%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −11,047.5% −5,102.5% n/a −771.6% −164.7% −240.4% −184.4% −149.3%
Net margin −10,797.9% −4,977.9% n/a −678.2% −209.8% −347.6% −222.8% −175.3%
Free cash flow margin −10,728.6% −5,211.1% n/a −698.2% −185.6% −176.5% −176.0% −173.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−121.4Capital expenditure−0.9Free cash flow−122.3Buybacks0.0Fiscal year 2019Operating cash flow−121.6Capital expenditure−0.4Free cash flow−121.9Buybacks−0.1Fiscal year 2020Operating cash flow−168.7Capital expenditure−0.8Free cash flow−169.5Buybacks0.0Fiscal year 2021Operating cash flow−233.4Capital expenditure−3.4Free cash flow−236.8Buybacks0.0Fiscal year 2022Operating cash flow−138.3Capital expenditure−0.7Free cash flow−139.0Fiscal year 2023Operating cash flow−118.7Capital expenditure−3.2Free cash flow−121.9Fiscal year 2024Operating cash flow−123.8Capital expenditure−0.9Free cash flow−124.7Fiscal year 2025Operating cash flow−141.2Capital expenditure−0.3Free cash flow−141.4
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −121.4 −121.6 −168.7 −233.4 −138.3 −118.7 −123.8 −141.2
Capital expenditure −0.9 −0.4 −0.8 −3.4 −0.7 −3.2 −0.9 −0.3
Free cash flow −122.3 −121.9 −169.5 −236.8 −139.0 −121.9 −124.7 −141.4
Growth
Buybacks 0.0 −0.1 0.0 0.0 n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash138.8Shareholders’ equity126.2Fiscal year 2019Cash115.6Total debt0.0Net cash (debt)115.6Shareholders’ equity111.2Debt to equity0.00Fiscal year 2020Cash439.2Total debt34.8Net cash (debt)404.4Shareholders’ equity335.5Debt to equity0.10Fiscal year 2021Cash466.5Total debt87.2Net cash (debt)379.4Shareholders’ equity154.0Debt to equity0.57Fiscal year 2022Cash326.4Shareholders’ equity79.5Fiscal year 2023Cash278.6Shareholders’ equity−148.2Fiscal year 2024Cash250.9Total debt0.0Net cash (debt)250.9Shareholders’ equity−202.6Fiscal year 2025Cash261.3Total debt3.0Net cash (debt)258.3Shareholders’ equity−185.8
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 138.8 115.6 439.2 466.5 326.4 278.6 250.9 261.3
Total debt n/a 0.0 34.8 87.2 n/a n/a 0.0 3.0
Net cash (debt) n/a 115.6 404.4 379.4 n/a n/a 250.9 258.3
Shareholders’ equity 126.2 111.2 335.5 154.0 79.5 −148.2 −202.6 −185.8
Debt to equity n/a 0.00 0.10 0.57 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−121.4 −121.6 −168.7 −233.4 −138.3 −118.7 −123.8 −141.2
Growth
Investment
−0.9 −0.4 −0.8 −3.4 −0.7 −3.2 −0.9 −0.3
calc −122.3 −121.9 −169.5 −236.8 −139.0 −121.9 −124.7 −141.4
Growth
calc n/a n/a n/a n/a −1.78 −1.49 −1.28 −1.11
−2.5 −2.2 −2.8 −6.7 −0.7 −3.2 −0.9 0.4
Financing
−0.0 100.5 495.0 267.4 −0.9 73.9 97.1 150.9
0.0 −0.1 0.0 0.0 n/a n/a n/a n/a

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.